Luye Pharma Group (2186.HK) Earnings Analysis
Luye Pharma Group (2186.HK) next reports earnings on 2026-08-27, consensus EPS 0.05773 HKD. Last quarter (2026-03-29) it beat with EPS 0.08903 HKD vs 0.08903 HKD est (0%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E 11.48.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2186.HK next report earnings?
| Next earnings date | 2026-08-27 |
|---|---|
| Consensus EPS estimate | 0.05773 HKD |
| Revenue estimate | 3.65B |
2186.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-29 | 0.08903 HKD | 0.08903 HKD | 0% | Beat |
| 2025-08-28 | 0.09117 HKD | 0.07671 HKD | +18.9% | Beat |
| 2025-03-30 | 0.02377 HKD | 0.1171 HKD | -79.7% | Miss |
| 2024-08-28 | 0.1107 HKD | n/a | n/a | n/a |
Beat rate: 2/3 (67%) over reported quarters with consensus data.
2186.HK valuation and analyst view
| Trailing P/E | 11.48 |
|---|---|
| Trailing EPS | 0.15349 HKD |
| Price / book | 0.46 |
| Dividend yield | 0.00% |
| Market cap | 8.43B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Luye Pharma Group (2186.HK)'s next earnings date?
Luye Pharma Group is next scheduled to report on 2026-08-27, with a consensus EPS estimate of 0.05773 HKD and revenue estimate of 3.65B.
Did 2186.HK beat earnings last quarter?
In its 2026-03-29 report, 2186.HK posted EPS of 0.08903 HKD versus a 0.08903 HKD estimate — a beat of 0%.
What is 2186.HK's earnings track record?
Over the last 3 reported quarters with consensus data, 2186.HK beat estimates 2 times (67%).
What is 2186.HK's current P/E ratio and EPS?
2186.HK trades at a trailing P/E of 11.48 on trailing EPS of 0.15349269319440895 HKD.
What do analysts rate 2186.HK?
2186.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.